- Home
- INKT vs PYN Comparison
INKT vs PYN Comparison
Compare INKT & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- PYN
- Stock Information
- Founded
- INKT 2017
- PYN 2002
- Country
- INKT United States
- PYN United States
- Employees
- INKT N/A
- PYN N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- PYN Investment Managers
- Sector
- INKT Health Care
- PYN Finance
- Exchange
- INKT Nasdaq
- PYN Nasdaq
- Market Cap
- INKT 28.8M
- PYN 30.1M
- IPO Year
- INKT 2021
- PYN N/A
- Fundamental
- Price
- INKT $40.61
- PYN $5.24
- Analyst Decision
- INKT Buy
- PYN
- Analyst Count
- INKT 3
- PYN 0
- Target Price
- INKT $37.50
- PYN N/A
- AVG Volume (30 Days)
- INKT 2.6M
- PYN 19.9K
- Earning Date
- INKT 08-12-2025
- PYN 01-01-0001
- Dividend Yield
- INKT N/A
- PYN 5.07%
- EPS Growth
- INKT N/A
- PYN N/A
- EPS
- INKT N/A
- PYN N/A
- Revenue
- INKT N/A
- PYN N/A
- Revenue This Year
- INKT N/A
- PYN N/A
- Revenue Next Year
- INKT N/A
- PYN N/A
- P/E Ratio
- INKT N/A
- PYN N/A
- Revenue Growth
- INKT N/A
- PYN N/A
- 52 Week Low
- INKT $4.56
- PYN $4.84
- 52 Week High
- INKT $76.00
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- INKT 68.63
- PYN 43.64
- Support Level
- INKT $6.80
- PYN $5.25
- Resistance Level
- INKT $76.00
- PYN $5.37
- Average True Range (ATR)
- INKT 5.71
- PYN 0.10
- MACD
- INKT 4.21
- PYN 0.01
- Stochastic Oscillator
- INKT 48.86
- PYN 4.30
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.